DGX vs SEER · P/E 22, rev $5.94B vs rev $5.9M
Quest Diagnostics Incorporated (DGX) versus Seer Inc (SEER) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Seer Inc (SEER) is a biotechnology company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported SEER revenue for 2026-06-30 was $5.9M. Net income was -$33.7M. SEER currently screens at market cap $94.6M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. SEER currently screens at market cap $94.6M.
Not investment advice. Open the DGX and SEER stock pages for the full models.
Not investment advice.